Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-18-014101
Filing Date
2018-10-18
Accepted
2018-10-18 17:05:48
Documents
4

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b5101518_actinium.htm 424B5 558576
2 GRAPHIC image_001.jpg GRAPHIC 7873
3 GRAPHIC img_01.jpg GRAPHIC 25442
4 GRAPHIC img_001.jpg GRAPHIC 5905
  Complete submission text file 0001213900-18-014101.txt   614070
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-216748 | Film No.: 181128845
SIC: 2834 Pharmaceutical Preparations